|
ABT
|
Abbott Laboratories
|
US
|
NYSE
|
|
ABUS
|
Arbutus Biopharma Corporation
|
US
|
NASDAQ
|
|
ADMA
|
ADMA Biologics Inc
|
US
|
NASDAQ
|
|
ADMP
|
Adamis Pharmaceuticals Corporation
|
US
|
NASDAQ
|
|
ADPT
|
Adaptive Biotechnologies Corporation
|
US
|
NASDAQ
|
|
AEMD
|
Aethlon Medical, Inc.
|
US
|
NASDAQ
|
|
AGEN
|
Agenus Inc.
|
US
|
NASDAQ
|
|
AIM
|
AIM ImmunoTech Inc.
|
US
|
AMEX
|
|
ANTX
|
AN2 Therapeutics, Inc.
|
US
|
NASDAQ
|
|
APM
|
Aptorum Group Limited
|
US
|
NASDAQ
|
|
ARDS
|
Aridis Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
BAX
|
Baxter International Inc.
|
US
|
NYSE
|
|
BDX
|
Becton, Dickinson and Company
|
US
|
NYSE
|
|
BDXB
|
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
|
US
|
NYSE
|
|
BJDX
|
Bluejay Diagnostics, Inc.
|
US
|
NASDAQ
|
|
BLRX
|
BioLineRx Ltd.
|
US
|
NASDAQ
|
|
BNTX
|
BioNTech SE
|
US
|
NASDAQ
|
|
BWV
|
Blue Water Vaccines, Inc.
|
US
|
NASDAQ
|
|
CDAK
|
Codiak BioSciences, Inc.
|
US
|
NASDAQ
|
|
CDTX
|
Cidara Therapeutics, Inc.
|
US
|
NASDAQ
|